PT  - JOURNAL ARTICLE
AU  - Huang, Xin
AU  - Yao, Minhao
AU  - Tian, Peixin
AU  - Wong, Jason Y.Y.
AU  - Li, Zilin
AU  - Liu, Zhonghua
AU  - Zhao, Jie V.
TI  - Shared genetic etiology and causality between COVID-19 and venous thromboembolism: evidence from genome-wide cross trait analysis and bi-directional Mendelian randomization study
AID  - 10.1101/2022.05.21.22275413
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.05.21.22275413
4099  - http://medrxiv.org/content/early/2022/06/01/2022.05.21.22275413.short
4100  - http://medrxiv.org/content/early/2022/06/01/2022.05.21.22275413.full
AB  - Venous thromboembolism (VTE) occurs in up to one third patients with COVID-19. VTE and COVID-19 may share a common genetic architecture, which has not been clarified yet. To fill this gap, we leveraged summary-level genetic data from the latest COVID-19 host genetics consortium and UK Biobank and examined the shared genetic etiology and causal relationship between COVID-19 and VTE. The cross-trait analysis identified 8, 11, and 7 shared loci between VTE and severe COVID-19, COVID-19 hospitalization, SARS-CoV-2 infection respectively, in 13 genes involved in coagulation and immune function and enriched in the lung. Co-localization analysis identified eight shared loci in ABO, ADAMTS13 and FUT2 genes. Bi-direction Mendelian randomization suggested that VTE was associated with higher risks of all COVID-19 related traits, and SARS-CoV-2 infection was associated with higher risk of VTE. Our study provided timely evidence and novel insights into the genetic etiology between COVID-19 and VTE.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Genetic associations with VTE were from the UK biobank GWAS results provided by Lee Lab (https://www.leelabsg.org/resources). Genetic associations with severe COVID-19, COVID-19 hospitalization and SARS-CoV-2 infection was obtained from COVID-19 host genetics consortium GWAS meta-analyses round 7, downloaded from https://www.covid19hg.org/results/r7/.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGenetic associations with VTE were from the UK biobank GWAS results provided by Lee Lab (https://www.leelabsg.org/resources). Genetic associations with severe COVID-19, COVID-19 hospitalization and SARS-CoV-2 infection was obtained from COVID-19 host genetics consortium GWAS meta-analyses round 7, downloaded from https://www.covid19hg.org/results/r7/. https://www.covid19hg.org/results/ https://www.leelabsg.org/resources